Cannasouth (NZX:CBD)
Cannasouth (NZX: CBD) is a Waikato-based company developing the next-generation of high-quality medicinal cannabis products. It operates through three segments – Cannasouth Bioscience for research and development, Cannasouth Cultivation, a cultivation facility to produce high-quality premium flower, and Eqalis Pharmaceuticals, conducting the manufacture of GMP medicinal cannabis ingredients and finished dosage form.